Literature DB >> 9307655

The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin.

W Peters1, B L Robinson.   

Abstract

Two interactions of two potent blood schizontocides, pyronaridine and artemisinin, were assessed in mice infected with chloroquine-resistant Plasmodium yoelii ssp. NS or one of two lines derived from it, namely ART, which is resistant to artemisinin and SPN, which is resistant to pyronaridine. While the drug combination proved to be only additive in its action against P. yoelii ssp. NS, a marked potentiation between the two compounds was observed against the ART and SPN lines. The implications of the findings in terms of the impeding of drug resistance when these compounds are deployed for the treatment of multi-drug-resistant P. falciparum are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307655     DOI: 10.1080/00034983.1997.11813123

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  5 in total

1.  In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum.

Authors:  P Ringwald; E C Eboumbou; J Bickii; L K Basco
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 2.  Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Joseph Pryce; Melissa Taylor; Tilly Fox; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2022-06-21

3.  Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase Model.

Authors:  Winter A Okoth; Elijah J Dukes; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

4.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

5.  Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Joseph Pryce; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2019-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.